Welcome to our dedicated page for Envoy Medical SEC filings (Ticker: COCH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding a medical-device company鈥檚 disclosures is no small task, and Envoy Medical鈥檚 SEC filings add layers of clinical data, FDA correspondence, and nuanced revenue recognition to the usual financial statements. If you have ever sifted through hundreds of pages hunting for R&D burn rates or insider activity, you know the challenge behind Envoy Medical SEC filings explained simply.
Stock Titan solves that problem. Our AI reads every Envoy Medical quarterly earnings report 10-Q filing and annual report 10-K simplified, flags pivotal trial expenses, and turns dense footnotes into plain-English highlights. AG真人官方-time alerts land the moment an Envoy Medical Form 4 insider transactions real-time notice is posted, while side-by-side comparisons let you spot shifts in cash runway between quarters. Whether you are understanding Envoy Medical SEC documents with AI for the first time or need rapid Envoy Medical earnings report filing analysis, our platform keeps you current without drowning you in jargon.
Use the tools professionals rely on:
- Monitor Envoy Medical insider trading Form 4 transactions minutes after they hit EDGAR.
- Spot segment-level spending trends pulled from each Envoy Medical quarterly earnings report 10-Q filing.
- Track regulatory breakthroughs via Envoy Medical 8-K material events explained.
- Review pay-for-performance alignment inside the Envoy Medical proxy statement executive compensation sections.
- Stay ahead of catalysts with notifications on every Envoy Medical executive stock transactions Form 4.
From FDA milestone disclosures to liquidity analyses, Stock Titan鈥檚 AI surfaces what matters so you can act faster and smarter.
Envoy Medical, Inc. disclosed that it and certain related parties entered into a Voting and Warrant Extension Agreement dated September 4, 2025. The agreement extends the expiration date of warrants held by GAT Funding, LLC and related Taylor parties to December 31, 2028. Prior to the extension those warrants had staggered expirations between February 27, 2026 and June 26, 2027.
The filing identifies Glen A. Taylor and affiliated entities as the warrant holders and notes Mr. Taylor directly or indirectly owns approximately 47.8% of the Company鈥檚 outstanding Class A Common Stock. The document is filed on Form 8-K and includes the Voting and Warrant Extension Agreement as an exhibit.
Envoy Medical, Inc. (COCH) insider filing by Glen A. Taylor reports multiple warrant amendments and related ownership disclosures. The filing shows Mr. Taylor as a director and >10% owner through direct holdings and indirect interests via Taylor Sports Group and GAT Funding, LLC. He disposed of 2,953,607 Class A shares and retains indirect and direct beneficial ownership positions: 2,526,058 shares indirectly and 4,810,384 shares indirectly via GAT Funding, LLC. The Form 4 documents cancellation of several "old" warrants and issuance of replacement warrants on 09/04/2025; replacement warrants are fully exercisable and, for several series, extend exercise expirations to 12/31/2028 while some near-term cancelled warrants show zero remaining post-transaction balances.
Envoy Medical, Inc. filed an 8-K reporting the satisfaction of promissory notes between the company and GAT Funding, LLC, effective August 25, 2025. The filing references termination of a material definitive agreement and notes related disclosure items for director or officer changes without providing specific names or details in the text provided.
The filing lists the company's securities (Class A Common Stock, COCH; Redeemable Warrants, COCHW) and attaches a press release dated August 26, 2025. The document is signed by Brent T. Lucas, Chief Executive Officer.
Alta Partners LLC filed a Schedule 13G reporting beneficial ownership of 1,944,139 shares of Envoy Medical, Inc. Class A common stock (shares issuable upon exercise of warrants), representing 8.25% of the class. Alta Partners reports sole voting and dispositive power over these shares and certifies the position was acquired and is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
FAQ
What is the current stock price of Envoy Medical (COCH)?
What is the market cap of Envoy Medical (COCH)?
